MONTREAL, CANADA--(Marketwire - September 09, 2008) - ART Advanced Research Technologies Inc. ("ART") (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced today that current research relating to its molecular imaging products will be presented at the World Molecular Imaging Congress (WMIC), being held at the Nice Acropolis Convention Centre in Nice, France, from September 10 to 13, 2008. ART is also featuring the Optix® and Fenestra® preclinical product offering as an exhibitor at the event (booth #211), in the Exhibit Hall of the Nice Acropolis Convention Center.
